Trial
NCT02524288
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Organon and Co
Collaborators
—
Condition
Contraception
Intervention
ENG-E2 125 μg/300 μg vaginal ring
Why stopped
This study was terminated by the Sponsor due to a business decision to discontinue product development for reasons unrelated to safety or efficacy outcomes.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-05-17